Literature DB >> 22090018

[The new TNM classification of tumors of the esophagogastric junction. Surgical consequences].

C Schuhmacher1, A Novotny, M Feith, H Friess.   

Abstract

The new International Union Against Cancer (UICC) classification in its seventh version has been out since January 2010. It included some important changes for the classification of esophageal and gastric carcinomas compared to the sixth version. For esophageal carcinomas this means a more detailed subdivision of the T and N stages which should, together with the newly introduced prognostic grouping (separate for squamous cell carcinoma and adenocarcinoma) enable a more precise and individualized prediction of prognosis. Another innovation is that positive lymph nodes in the esophageal drainage area, including celiac axis nodes and paraesophageal lymph nodes in the neck, are classified as regional lymph node metastases rather than distant metastatic spread, irrespective of tumor location. Hereby the lymphadenectomy specimen should include  ≥ 6 lymph nodes (LN). The most controversial improvement is that adenocarcinomas of the esophagogastric junction (AEG) are all classified as esophageal carcinomas. This should acknowledge the similar prognosis of AEGs and esophageal carcinomas, which is worse compared to gastric carcinomas in other locations. Regarding the classification of gastric carcinomas the T-stages were redefined and lymph node staging (N-stage) was refined to allow for a better prediction of prognosis. The lymphadenectomy specimen after gastrectomy should hereby include  ≥ 16 LNs. As the primary aim of the UICC classification is a preferably accurate prognosis prediction, the impact on a surgeon's therapeutic decision is low. For decisions regarding the type of resection the endoscopic AEG classification with the aim of R0 resections is still the instrument of choice. The value of the UICC classification is that it enables sophisticated comparisons between different treatment regimens and strategies.

Entities:  

Mesh:

Year:  2012        PMID: 22090018     DOI: 10.1007/s00104-011-2146-0

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  9 in total

1.  How to classify adenocarcinomas of the esophagogastric junction: as esophageal or gastric cancer?

Authors:  Ralf Gertler; Hubert J Stein; Martin Loos; Rupert Langer; Helmut Friess; Marcus Feith
Journal:  Am J Surg Pathol       Date:  2011-10       Impact factor: 6.394

2.  A prospective randomized comparison of transhiatal and transthoracic resection for lower-third esophageal carcinoma.

Authors:  K M Chu; S Y Law; M Fok; J Wong
Journal:  Am J Surg       Date:  1997-09       Impact factor: 2.565

3.  Classification of adenocarcinoma of the oesophagogastric junction.

Authors:  J R Siewert; H J Stein
Journal:  Br J Surg       Date:  1998-11       Impact factor: 6.939

4.  [German S3-guideline "Diagnosis and treatment of esophagogastric cancer"].

Authors:  M Moehler; S-E Al-Batran; T Andus; M Anthuber; J Arends; D Arnold; D Aust; P Baier; G Baretton; J Bernhardt; H Boeing; E Böhle; C Bokemeyer; J Bornschein; W Budach; E Burmester; K Caca; W A Diemer; C F Dietrich; M Ebert; A Eickhoff; C Ell; J Fahlke; H Feussner; R Fietkau; W Fischbach; W Fleig; M Flentje; H E Gabbert; P R Galle; M Geissler; I Gockel; U Graeven; L Grenacher; S Gross; J T Hartmann; M Heike; V Heinemann; B Herbst; T Herrmann; S Höcht; R D Hofheinz; H Höfler; T Höhler; A H Hölscher; M Horneber; J Hübner; J R Izbicki; R Jakobs; C Jenssen; S Kanzler; M Keller; R Kiesslich; G Klautke; J Körber; B J Krause; C Kuhn; F Kullmann; H Lang; H Link; F Lordick; K Ludwig; M Lutz; R Mahlberg; P Malfertheiner; S Merkel; H Messmann; H-J Meyer; S Mönig; P Piso; S Pistorius; R Porschen; T Rabenstein; P Reichardt; K Ridwelski; C Röcken; I Roetzer; P Rohr; W Schepp; P M Schlag; R M Schmid; H Schmidberger; W-H Schmiegel; H-J Schmoll; G Schuch; C Schuhmacher; K Schütte; W Schwenk; M Selgrad; A Sendler; J Seraphin; T Seufferlein; M Stahl; H Stein; C Stoll; M Stuschke; A Tannapfel; R Tholen; P Thuss-Patience; K Treml; U Vanhoefer; M Vieth; H Vogelsang; D Wagner; U Wedding; A Weimann; H Wilke; C Wittekind
Journal:  Z Gastroenterol       Date:  2011-04-07       Impact factor: 2.000

5.  Anatomical basis for the approach and extent of surgical treatment of esophageal cancer.

Authors:  D Liebermann-Meffert
Journal:  Dis Esophagus       Date:  2001       Impact factor: 3.429

6.  Evaluation of the seventh American Joint Committee on Cancer/International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classification.

Authors:  Hye Seong Ahn; Hyuk-Joon Lee; Seokyung Hahn; Woo-Ho Kim; Kuhn Uk Lee; Takeshi Sano; Stephen B Edge; Han-Kwang Yang
Journal:  Cancer       Date:  2010-08-24       Impact factor: 6.860

7.  Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals.

Authors:  Thomas W Rice; Valerie W Rusch; Hemant Ishwaran; Eugene H Blackstone
Journal:  Cancer       Date:  2010-08-15       Impact factor: 6.860

8.  Long-term outcome of 2920 patients with cancers of the esophagus and esophagogastric junction: evaluation of the New Union Internationale Contre le Cancer/American Joint Cancer Committee staging system.

Authors:  Ralf Gertler; Hubert J Stein; Rupert Langer; Marc Nettelmann; Tibor Schuster; Heinz Hoefler; Joerg-Ruediger Siewert; Marcus Feith
Journal:  Ann Surg       Date:  2011-04       Impact factor: 12.969

9.  Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus.

Authors:  Jan B F Hulscher; Johanna W van Sandick; Angela G E M de Boer; Bas P L Wijnhoven; Jan G P Tijssen; Paul Fockens; Peep F M Stalmeier; Fiebo J W ten Kate; Herman van Dekken; Huug Obertop; Hugo W Tilanus; J Jan B van Lanschot
Journal:  N Engl J Med       Date:  2002-11-21       Impact factor: 91.245

  9 in total
  5 in total

1.  [Hospital volume effects in surgical treatment of gastric cancer : Results of a prospective multicenter observational study].

Authors:  H Ptok; I Gastinger; F Meyer; A Ilsemann; H Lippert; C Bruns
Journal:  Chirurg       Date:  2017-04       Impact factor: 0.955

2.  Correlations of MUC15 overexpression with clinicopathological features and prognosis of glioma.

Authors:  Wen-Bing Yang; Cheng-Yan Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-04-08

Review 3.  [Differentiated surgical approach for adenocarcinoma of the gastroesophageal junction].

Authors:  W Schröder; R Lambertz; R van Hillegesberger; C Bruns
Journal:  Chirurg       Date:  2017-12       Impact factor: 0.955

4.  GEJ cancers: gastric or esophageal tumors? searching for the answer according to molecular identity.

Authors:  Williams Fernandes Barra; Fabiano Cordeiro Moreira; Aline Maria Pereira Cruz; André Salim Khayat; Danielle Queiroz Calcagno; Ney Pereira Carneiro Dos Santos; Rui Wanderley Mascarenhas Junior; Taíssa Maíra Thomaz Araújo; Geraldo Ishak; Samia Demachki; Rommel Mario Rodríguez Burbano; Ândrea Kely Campos Ribeiro Dos Santos; Sidney Emanuel Batista Dos Santos; Gregory Joseph Riggins; Paulo Pimentel de Assumpção
Journal:  Oncotarget       Date:  2017-10-31

5.  Surgical approach for Siewert type II adenocarcinoma of the esophagogastric junction: transthoracic or transabdominal? -a single-center retrospective study.

Authors:  Zi-Feng Yang; De-Qing Wu; Jun-Jiang Wang; Xing-Yu Feng; Jia-Bin Zheng; Wei-Xian Hu; Yong Li
Journal:  Ann Transl Med       Date:  2018-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.